Anbio Biotechnology
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $3.89
- 52-Week Range
- $3.09 – $44.73
- Market Cap
- $158.01M
- P/E (TTM)
- 24.00
- EPS (TTM)
- 0.15
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 5.24
- PEG Ratio
- —
- Return on Equity
- 27.05%
- Return on Assets
- 14.66%
- Gross Margin
- 87.24%
- Operating Margin
- 66.70%
- Profit Margin
- 74.06%
- Current Ratio
- 344.31
- Debt/Equity
- —
- Total Debt
- $0.00
- Free Cash Flow
- $-9.61M
- Revenue Growth
- 73.90%
- Earnings Growth
- —
- Enterprise Value
- $146.11M
Market Snapshot
About
Anbio Biotechnology is a Chinese biotech company specializing in in-vitro diagnostic products and rapid testing solutions for medical applications.